TRUE regarding the main function of Apoprotein C II
Wait, Apo C II is a coenzyme for lipoprotein lipase. That's right. Lipoprotein lipase breaks down triglycerides in chylomicrons and VLDL. So, Apo C II activates this enzyme. Therefore, when Apo C II is present, it helps in the hydrolysis of triglycerides. That's the core concept here.
Now, the options weren't provided, but the correct answer is about being a coenzyme for lipoprotein lipase. Let's think about other apolipoproteins. For example, Apo A-I is in HDL and involved in reverse cholesterol transport. Apo B-100 is in LDL and binds to receptors. Apo C III inhibits lipoprotein lipase. So if the options included these, they would be incorrect because they have different roles.
The clinical pearl here is that deficiency in Apo C II can lead to hypertriglyceridemia because lipoprotein lipase isn't activated. Also, LPL is crucial for breaking down triglycerides, so without Apo C II, this process is impaired.
I need to structure the explanation with the core concept, why the correct answer is right, why others are wrong, and a clinical pearl. Make sure to mention the activation of LPL and the role in triglyceride breakdown. Also, note that other apolipoproteins have distinct functions that don't align with the question.
**Core Concept**
Apoprotein C II (Apo C II) is a critical **coactivator of lipoprotein lipase (LPL)**, an enzyme responsible for hydrolyzing triglycerides in chylomicrons and very-low-density lipoproteins (VLDL). This process is essential for **releasing free fatty acids** to peripheral tissues and **clearing triglyceride-rich lipoproteins** from the bloodstream.
**Why the Correct Answer is Right**
Apo C II binds to and **activates lipoprotein lipase**, enabling it to break down triglycerides into free fatty acids and glycerol. This activation is vital for **lipid metabolism**, as LPL activity is otherwise insufficient to process circulating lipoproteins. Without Apo C II, triglyceride clearance is impaired, leading to **hypertriglyceridemia**, a hallmark of deficiencies or mutations in this apolipoprotein.
**Why Each Wrong Option is Incorrect**
**Option A:** *If incorrect*, likely refers to Apo A-I (reverse cholesterol transport mediator) or Apo B-100 (LDL receptor ligand). These have distinct roles unrelated to LPL activation.
**Option B:** *If incorrect*, may describe Apo C III (LPL inhibitor) or Apo E (LDL receptor ligand). These apolipoproteins antagonize or regulate LPL differently.
**Option C/D:** *If incorrect*, could involve Apo B-48 (chylomicron structural component